130 related articles for article (PubMed ID: 2452506)
1. [Value of commercial enzyme immunoassays in the determination of prostatic acid phosphatase].
Rassweiler J; Lutz K; Müller HA; Eisenberger F
Urologe A; 1988 Jan; 27(1):32-5. PubMed ID: 2452506
[TBL] [Abstract][Full Text] [Related]
2. [Significance of an immunoenzyme assay of the prostate-specific acid phosphatase (PAP) (E.C.3.1.3.2.) in prostatic carcinoma. Methods and initial clinical results].
Bauer HW; Schmiedt E
Urologe A; 1983 Sep; 22 Suppl():367-71. PubMed ID: 6195796
[TBL] [Abstract][Full Text] [Related]
3. [Measurements of prostatic acid phosphatase and prostate specific antigen by fully automated enzyme immunoassay system--its analytical and clinical evaluation].
Matui A; Yamada T; Sugita O; Yakata M
Rinsho Byori; 1990 Jun; 38(6):693-8. PubMed ID: 1696328
[TBL] [Abstract][Full Text] [Related]
4. [Determination of tumor markers in the diagnosis of prostatic cancer].
Casas Terrón E; Mari Ruiz M; Molina Andreu E
Arch Esp Urol; 1993 Mar; 46(2):99-103. PubMed ID: 7684585
[TBL] [Abstract][Full Text] [Related]
5. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
[TBL] [Abstract][Full Text] [Related]
6. [Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer].
Watanabe M; Kitamura Y; Komatsubara S; Sakata Y
Hinyokika Kiyo; 1988 Dec; 34(12):2135-41. PubMed ID: 2467542
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of serum prostatic acid phosphatase assay based on the immunoenzymatic method (TZR-516)].
Ikemoto I; Machida T; Oishi Y; Onishi T; Shirai T; Imanaka K
Hinyokika Kiyo; 1989 Sep; 35(9):1639-42. PubMed ID: 2479240
[TBL] [Abstract][Full Text] [Related]
8. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
[TBL] [Abstract][Full Text] [Related]
9. Comparison of prostatic acid phosphatase assays.
Wise WS; Kandaswamy K
Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
[TBL] [Abstract][Full Text] [Related]
10. [Immunoenzyme assay for prostate-specific acid phosphatase in prostatic cancer].
Bauer HW
Med Welt; 1982 Nov; 33(46):1616-21. PubMed ID: 6185820
[No Abstract] [Full Text] [Related]
11. [Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase].
Gaca A; Panitz N
Helv Chir Acta; 1981 Aug; 48(3-4):465-6. PubMed ID: 7287485
[TBL] [Abstract][Full Text] [Related]
12. [Experience with prostate-specific antigen in patients with prostatic cancer].
Romics I; Bach D
Orv Hetil; 1989 Dec; 130(52):2797-800. PubMed ID: 2481833
[TBL] [Abstract][Full Text] [Related]
13. PSA excess in the differential diagnosis of prostate carcinoma.
Díaz F; Morell M; Rojo G
Arch Esp Urol; 1997 May; 50(4):415-8. PubMed ID: 9219422
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and follow-up of prostatic cancer using an enzyme immunoassay for prostate-specific acid phosphatase].
Bauer HW; Schüller J; Schmiedt E; Dati F
Helv Chir Acta; 1981 Aug; 48(3-4):459-63. PubMed ID: 7026510
[TBL] [Abstract][Full Text] [Related]
15. [Prostatic acid phosphatase by enzymeimmunoassay].
Masukagami T; Ando K; Shimazaki J
Hinyokika Kiyo; 1984 Nov; 30(11):1691-5. PubMed ID: 6084950
[TBL] [Abstract][Full Text] [Related]
16. [Immunochemical measurement of prostatic acid phosphatase in carcinoma of the prostate].
Cooper EH; Bauer HW; Dati F
Ric Clin Lab; 1984; 14 Suppl 2():39-55. PubMed ID: 6085183
[No Abstract] [Full Text] [Related]
17. [Determination of acid phosphatase in prostatic carcinoma].
Bauer HW; Walther V; Schmiedt F
Fortschr Med; 1980 Sep; 98(34):1301-5. PubMed ID: 7461538
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study of tumor markers in prostatic carcinoma--an investigation on the simultaneous measurement of prostatic acid phosphatase (PAP), prostatic antigen (PA) and gamma-seminoprotein (gamma-Sm)].
Tsukamoto T; Kumamoto Y; Yamazaki K; Umehara T; Miyao N; Ohmura K; Iwazawa M
Hinyokika Kiyo; 1988 Jun; 34(6):987-95. PubMed ID: 2464917
[TBL] [Abstract][Full Text] [Related]
19. [Reliability and use of prostate-specific antigen in the management of patients with prostatic cancer].
Hübler J; Jávor A
Orv Hetil; 1993 Jul; 134(28):1529-32. PubMed ID: 7688112
[TBL] [Abstract][Full Text] [Related]
20. [The diagnostic value of the radioimmunological estimation of prostatic acid phosphatase. Comparative value of the measurement of enzyme activity (author's transl)].
Tellier JL; Chatal JF; Bourdin S; Auvigne J; Etienne P; Faye R
J Urol (Paris); 1981; 87(3):169-73. PubMed ID: 7240777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
